Skip to main content
Crescita Therapeutics Inc. (TSX:CTX)
Canada flag Canada · Delayed Price · Currency is CAD
0.450
0.00 (0.00%)
Mar 6, 2026, 1:29 PM EST

Crescita Therapeutics Revenue

Crescita Therapeutics had revenue of 5.39M CAD in the quarter ending September 30, 2025, with 50.06% growth. This brings the company's revenue in the last twelve months to 22.07M, up 26.79% year-over-year. In the year 2024, Crescita Therapeutics had annual revenue of 19.58M with 11.75% growth.

Revenue (ttm)
22.07M
Revenue Growth
+26.79%
P/S Ratio
0.38
Revenue / Employee
n/a
Employees
62
Market Cap
8.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202419.58M2.06M11.75%
Dec 31, 202317.52M-6.00M-25.52%
Dec 31, 202223.53M6.76M40.29%
Dec 31, 202116.77M1.13M7.22%
Dec 31, 202015.64M-6.70M-29.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Christina Lake Cannabis 15.08M
Mercanto Holdings 3.09M
Avant Brands 35.90M
Nextleaf Solutions 11.40M
Blueberries Medical 413.97K
Medicure 26.21M
PharmaCielo 1.75M
Sweet Earth Holdings -5.61K
Revenue Rankings

Crescita Therapeutics News

More News